managing comorbidities in aml
Published 5 years ago • 19 plays • Length 3:36Download video MP4
Download video MP3
Similar videos
-
6:51
aml: managing aes with venetoclax azacitidine
-
2:39
managing treatment for idh2-mutated aml
-
5:40
toxicity management in the treatment of r/r aml
-
5:31
novel strategies in acute myeloid leukemia management
-
1:45
how to optimally manage relapse in aml
-
1:46
dr. pardee on comorbidities, age, and outcomes among intensively treated patients with aml
-
7:01
venetoclax azacitidine in frontline aml management
-
3:20
thrombosis, myelofibrosis, and acute myeloid leukemia
-
2:21
targeted therapies and the treatment of aml
-
3:54
managing tki therapy in cml
-
3:51
determining the treatment options for t-aml
-
3:22
case-based overview: newly diagnosed acute myeloid leukemia
-
1:03
targeted therapies in newly diagnosed aml: bcl2, flt3 and idh inhibitors
-
4:15
case 2: selecting a targeted therapy for aml with mrc
-
3:33
selecting therapy for newly diagnosed aml
-
2:38
flt3 inhibitors: revolutionizing the management of aml
-
31:33
managing life with aml | what you should know about care and treatment
-
6:25
case 3: targeting idh in aml
-
1:14:27
major treatment decisions for patients with acute myeloid leukemia (aml)